Abstract
Background After more than four months into the coronavirus disease (COVID-19) epidemic, over 347,500 people had died worldwide. The current study aims to evaluate how mitigating interventions affected the epidemic process in the 30 largest metropolitan areas in the US and whether temperature played a role in the epidemic process.
Methods Publicly available data for the time series of COVID-19 cases and deaths and weather were analyzed at the metropolitan level. The time-varying reproductive numbers (Rt) based on retrospective moving average were used to explore the trends. Student t tests were used to compare temperature and peak Rt cross-sectionally.
Results We found that virus transmissibility, measured by instantaneous reproduction number (Rt), had declined since the end of March for all areas and almost all of them reached a Rt of 1 or below after April 15, 2020. However, the Rts remained around 1 for most areas since then and some small and short rebounds were presented in some areas, suggesting a persistent epidemic in those areas. The timing of the main decline was concurrent with the implementation of mitigating interventions. Cities with warm temperature also tended to have a lower peak Rt than that of cities with cold temperature. However, large geographic variations existed.
Conclusions Aggressive interventions might have mitigated the current epidemic of COVID-19, while temperature might have some weak effects on the virus transmission. We may need to prepare for a possible return of the coronavirus outbreak.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Exempted from IRB approval, as the data are publicly available.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
